journal
Journals Clinical and Translational Rad...

Clinical and Translational Radiation Oncology

https://read.qxmd.com/read/38654940/letter-to-the-editor-reply-to-ali-et-al
#1
JOURNAL ARTICLE
Michael Sunmin Kim, Derek Roger Wilke
This is a response to the letter to the editor from Dr. Ali et al. from Aga Khan University, Karachi, Pakistan.
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38633470/methodological-guide-for-assessing-the-carbon-footprint-of-external-beam-radiotherapy-a-single-center-study-with-quantified-mitigation-strategies
#2
JOURNAL ARTICLE
David Ali, Max Piffoux
BACKGROUND AND PURPOSES: Data on the carbon footprint of external beam radiotherapy (EBRT) are scarce. Reliable and exhaustive data, including a detailed carbon inventory, are needed to determine effective mitigation strategies. MATERIALS AND METHODS: This study proposes a methodology for calculating the carbon footprint of EBRT and applies it to a single center. Mitigation strategies are derived from the carbon inventory, and their potential reductions are quantified whenever possible...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38628594/helical-tomotherapy-craniospinal-irradiation-in-primary-brain-tumours-toxicities-and-outcomes-in-a-peadiatric-and-adult-population
#3
JOURNAL ARTICLE
Julie Savagner, Anne Ducassou, Bastien Cabarrou, Gregory Hangard, Marion Gambart, Anne-Isabelle Bertozzi, Eloise Baudou, Sergio Boetto, Delphine Larrieu, Anne Laprie
OBJECTIVE: As craniospinal irradiation (CSI) is delivered more frequently by helical tomotherapy (HT) with few reports about late effects, we analysed all patients treated in our centre over an 11-year period. METHODS AND MATERIALS: Our study included all patients that underwent CSI by HT, between September 2009 and January 2020, in the Department of Radiation Oncology of the Toulouse Cancer Institute. Acute radiotherapy toxicities were reported and medium- to long-term outcomes analysed...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38596818/all-for-one-collaboration-between-dermatologist-radiation-oncologist-and-radiologist-in-the-clinical-management-of-difficult-to-treat-non-melanoma-skin-cancer
#4
Federico Gagliardi, Anna Russo, Camila Scharf, Alessandro Pinto, Mario Faenza, Emma D'Ippolito, Giuseppe Argenziano, Teresa Troiani, Alfonso Reginelli, Valerio Nardone
This series introduces the clinical management of difficult-to-treat non-melanoma skin cancers (NMSCs) through a multidisciplinary approach, emphasizing the integration of dermoscopy and Ultra high-frequency ultrasound (UHFUS) for accurate diagnosis and treatment planning, particularly in cases referred for radiotherapy (RT). Dermoscopy aids in diagnosing both pigmented and non-pigmented skin lesions, guiding treatment margins and reducing the benign-to-malignant biopsy ratio. UHFUS provides valuable insights into tumor size, depth, and vascularity, complementing clinical evaluations and assisting in RT planning...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38596817/in-regard-to-kim-et-al
#5
JOURNAL ARTICLE
Tooba Ali, Mariam Hina, Laraib Khan, Bilal Mazhar Qureshi, Asim Hafiz, Ahmed Nadeem Abbasi
No abstract text is available yet for this article.
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38596816/high-dose-loco-regional-pattern-of-failure-after-primary-radiotherapy-in-p16-positive-and-negative-head-and-neck-squamous-cell-carcinoma-a-dahanca-19-study
#6
JOURNAL ARTICLE
Morten Horsholt Kristensen, Anne Ivalu Sander Holm, Christian Rønn Hansen, Ruta Zukauskaite, Eva Samsøe, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, Jens Overgaard, Jesper Grau Eriksen
INTRODUCTION: Patients with failure after primary radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC) have a poor prognosis. This study investigates pattern of failure after primary curatively intended IMRT in a randomized controlled trial in relation to HPV/p16 status. MATERIAL AND METHODS: Patients with HNSCC of the oral cavity, oropharynx (OPSCC), hypopharynx or larynx were treated with primary curative IMRT (+/-cisplatin) and concomitant nimorazole between 2007 and 12...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38590328/quantifying-radiation-induced-breast-fibrosis-by-shear-wave-elastography-in-patients-with-breast-cancer-a-12-months-follow-up-data-of-a-prospective-study
#7
JOURNAL ARTICLE
Wonguen Jung, Jin Chung, Jihae Lee, Kyubo Kim
PURPOSE: To assess radiation-induced fibrosis (RIF) using shear-wave elastography (SWE) in patients with breast cancer who received radiotherapy (RT) after breast conserving surgery. METHODS: Forty-one patients were enrolled in a prospective study before RT. SWE and B-mode ultrasonography were performed to measure elasticity. For quantitative measurement, the maximum elasticity value was measured in the tumor bed and non-tumor bed of the treated breast, and contralateral breast before RT and at 3, and 12 months after RT...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38590327/stereotactic-ablative-radiotherapy-for-treating-primary-head-and-neck-cancer-and-locoregional-recurrence-a-comprehensive-review-of-the-literature
#8
JOURNAL ARTICLE
Ciro Franzese, Panagiotis Balermpas
INTRODUCTION: Although stereotactic ablative radiotherapy (SABR) has advance to standard-of-care for many different indications like lung and liver malignancies, it still remains in its infancy for treating head and neck cancer. Nevertheless there is a growing body of experience and evidence, which is summarized in this review Methods A thorough search of the literature was performed and critically reviewed both for SABR as a primary treatment as well as for treating locoregionally recurrent disease in a pre-irradiated field...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38586081/stereotactic-ultrahypofractionated-mr-guided-radiotherapy-for-localized-prostate-cancer-acute-toxicity-and-patient-reported-outcomes-in-the-prospective-multicenter-smile-phase-ii-trial
#9
JOURNAL ARTICLE
C A Fink, J Ristau, C Buchele, S Klüter, J Liermann, P Hoegen-Saßmannshausen, E Sandrini, A Lentz-Hommertgen, L Baumann, N Andratschke, M Baumgartl, M Li, M Reiner, S Corradini, J Hörner-Rieber, D Bonekamp, H-P Schlemmer, C Belka, M Guckenberger, J Debus, S A Koerber
BACKGROUND: Due to superior image quality and daily adaptive planning, MR-guided stereotactic body radiation therapy (MRgSBRT) has the potential to further widen the therapeutic window in radiotherapy of localized prostate cancer. This study reports on acute toxicity rates and patient-reported outcomes after MR-guided adaptive ultrahypofractionated radiotherapy for localized prostate cancer within the prospective, multicenter phase II SMILE trial. MATERIALS AND METHODS: A total of 69 patients with localized prostate cancer underwent MRgSBRT with daily online plan adaptation...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38586080/postmastectomy-radiation-therapy-in-breast-cancer-patients-with-micrometastatic-disease-in-sentinel-node-dissection-a-cohort-study-and-meta-analysis
#10
JOURNAL ARTICLE
Fatema Jafer, Stilda Malki, Mariam Akram, Tamana Gulwarisdotter, Andreas Karakatsanis, Antonis Valachis
AIM: The potential role of postmastectomy radiation therapy (PMRT) on prognosis in patients with T1-2 breast cancer and micrometastatic disease in sentinel lymph node dissection (SLND) has not yet been established. The aim of this study was to investigate the impact of PMRT on prognosis in patients with T1-2 breast cancer and micrometastatic in SLND. METHOD: A register- and population-based cohort was utilized by identifying eligible patients on the research database BcBase 3...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38586079/developing-and-validating-a-simple-urethra-surrogate-model-to-facilitate-dosimetric-analysis-to-predict-genitourinary-toxicity
#11
JOURNAL ARTICLE
Ragu Ratnakumaran, Jonathan Mohajer, Samuel J Withey, Douglas H Brand, Ernest Lee, Andrew Loblaw, Shaun Tolan, Nicholas van As, Alison C Tree
PURPOSE: The urethra is a critical structure in prostate radiotherapy planning; however, it is impossible to visualise on CT. We developed a surrogate urethra model (SUM) for CT-only planning workflow and tested its geometric and dosimetric performance against the MRI-delineated urethra (MDU). METHODS: The SUM was compared against 34 different MDUs (within the treatment PTV) in patients treated with 36.25Gy (PTV)/40Gy (CTV) in 5 fractions as part of the PACE-B trial...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38576855/stereotactic-body-radiation-therapy-in-patients-with-centrally-located-hepatocellular-carcinoma-a-retrospective-single-arm-multi-center-study
#12
JOURNAL ARTICLE
Dan-Xue Zheng, Yi-Xing Chen, Jing Sun, Yong Hu, Ping Yang, Yang Zhang, Xue-Zhang Duan, Zhao-Chong Zeng
Centrally located hepatocellular carcinoma (HCC) is difficult to be radically resected due to its special location close to major hepatic vessels. Thus, we aimed to assess whether stereotactic body radiation therapy (SBRT) can be an effective and safe approach for centrally located HCC. This retrospective study included 172 patients with centrally located HCC who were treated with SBRT. Overall survival (OS) was analyzed as the primary endpoint. Rates of progression-free survival (PFS), local control, intrahepatic relapse, extrahepatic metastasis and toxicities were analyzed as secondary endpoints...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38572302/metastases-directed-radiotherapy-in-castration-resistant-oligo-metastatic-prostate-cancer-a-multicentric-retrospective-study-from-the-french-group-colib
#13
JOURNAL ARTICLE
J Chamois, A L Septans, B Schipman, E Gross, N Blanchard, V Passerat, C Debelleix, C G Hemery, I Latorzeff, Y Pointreau
Oligometastases are defined as a number of detectable metastases less or equal to 5. In castrate-resistant oligo metastatic prostate Cancer (CR oligoM PC), Metastases-Directed Ablative radiotherapy (MDRT) is poorly investigated. Our study retrospectively reviewed the cases of CR oligoM PC treated with MDRT in 8 French high-volume radiotherapy centers. OS and PFS are defined as the delay between the first day of MDRT and death (OS) or progression according to PCWG criteria (PFS). OS and PFS are evaluated according to Kaplan Meyer, curves are compared with log rank test...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38560512/intrafractional-motion-detection-for-spine-sbrt-via-x-ray-imaging-using-exactrac-dynamic
#14
JOURNAL ARTICLE
Johannes Muecke, Daniel Reitz, Lili Huang, Vanessa da Silva Mendes, Guillaume Landry, Michael Reiner, Claus Belka, Philipp Freislederer, Stefanie Corradini, Maximilian Niyazi
PURPOSE: Due to its close vicinity to critical structures, especially the spinal cord, standards for safety for spine stereotactic body radiotherapy (SBRT) should be high. This study was conducted, to evaluate intrafractional motion during spine SBRT for patients without individualized immobilization (e.g., vacuum cushions) using high accuracy patient monitoring via orthogonal X-ray imaging. METHODS: Intrafractional X-ray data were collected from 29 patients receiving 79 fractions of spine SBRT...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38550309/individual-benefit-in-heart-sparing-during-dibh-supported-left-breast-radiotherapy
#15
JOURNAL ARTICLE
Szilvia Gaál, Zsuzsanna Kahán, Ferenc Rárosi, Gergely H Fodor, József Tolnai, Bence Deák, Katalin Hideghéty, Zoltán Varga
INTRODUCTION: Deep-inspirational breath hold (DIBH) is an option for heart protection in breast radiotherapy; we intended to study its individual benefit. MATERIALS AND METHODS: 3DCRT treatment planning was performed in a cohort of 103 patients receiving radiotherapy of the whole breast (WBI)/chest wall (CWI) ± nodal regions (NI) both under DIBH and free breathing (FB) in the supine position, and in the WBI only cases prone (n = 45) position, too...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38516338/ultra-hypofractionated-one-week-locoregional-radiotherapy-for-patients-with-early-breast-cancer-acute-toxicity-results
#16
JOURNAL ARTICLE
Ivica Ratosa, Angel Montero, Raquel Ciervide, Beatriz Alvarez, Mariola García-Aranda, Jeannette Valero, Xin Chen-Zhao, Mercedes Lopez, Daniel Zucca, Ovidio Hernando, Emilio Sánchez, Miguel Angel de la Casa, Rosa Alonso, Pedro Fernandez-Leton, Carmen Rubio
PURPOSE: Moderate hypofractionated radiotherapy is the standard of care for all patients with breast cancer, irrespective of stage or prior treatments. While extreme hypofractionation is accepted for early-stage tumours, its application in irradiating locoregional lymph nodes remains controversial. MATERIALS AND METHODS: A prospective registry analysis from July 2020 to September 2023 included 276 patients with early-stage breast cancer treated with one-week ultra-hypofractionation (UHF) at 26 Gy in 5 fractions on the whole breast (58...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38510980/mr-guided-stereotactic-radiation-therapy-for-head-and-neck-cancers
#17
JOURNAL ARTICLE
He Wang, Jinzhong Yang, Anna Lee, Jack Phan, Tze Yee Lim, Clifton D Fuller, Eun Young Han, Dong Joo Rhee, Travis Salzillo, Yao Zhao, Nitish Chopra, Mary Pham, Pam Castillo, Angela Sobremonte, Amy C Moreno, Jay P Reddy, David Rosenthal, Adam S Garden, Xin Wang
PURPOSE: MR-guided radiotherapy (MRgRT) has the advantage of utilizing high soft tissue contrast imaging to track daily changes in target and critical organs throughout the entire radiation treatment course. Head and neck (HN) stereotactic body radiation therapy (SBRT) has been increasingly used to treat localized lesions within a shorter timeframe. The purpose of this study is to examine the dosimetric difference between the step-and-shot intensity modulated radiation therapy (IMRT) plans on Elekta Unity and our clinical volumetric modulated arc therapy (VMAT) plans on Varian TrueBeam for HN SBRT...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38500668/management-of-glioblastoma-in-elderly-patients-a-review-of-the-literature
#18
REVIEW
Nektarios K Mazarakis, Stephen D Robinson, Priyank Sinha, Christos Koutsarnakis, Spyridon Komaitis, George Stranjalis, Susan C Short, Paul Chumas, Georgios Giamas
High grade gliomas are the most common primary aggressive brain tumours with a very poor prognosis and a median survival of less than 2 years. The standard management protocol of newly diagnosed glioblastoma patients involves surgery followed by radiotherapy, chemotherapy in the form of temozolomide and further adjuvant temozolomide. The recent advances in molecular profiling of high-grade gliomas have further enhanced our understanding of the disease. Although the management of glioblastoma is standardised in newly diagnosed adult patients there is a lot of debate regarding the best treatment approach for the newly diagnosed elderly glioblastoma patients...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38500667/influence-of-intestinal-microbial-metabolites-on-the-abscopal-effect-after-radiation-therapy-combined-with-immune-checkpoint-inhibitors
#19
JOURNAL ARTICLE
Hannah Felchle, Julia Gissibl, Laura Lansink Rotgerink, Sophie M Nefzger, Caroline N Walther, Vincent R Timnik, Stephanie E Combs, Julius C Fischer
BACKGROUND: Most clinical studies failed to elicit a strong antitumor immune response and subsequent systemic tumor regression after radiation therapy (RT), even in combination with the immune checkpoint inhibitors (ICI) anti-CTLA4 or anti-PD1. Mechanistically, type I interferon (IFN-I) activation is essential for the development of such abscopal effects (AE); however, mechanisms driving or limiting IFN-I activation are ill defined. Groundbreaking discoveries have shown that antibiotics (ABx) can affect oncological outcomes and that microbiota-derived metabolites can modulate systemic antitumor immunity...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38495648/personalizing-dental-screening-and-prevention-protocols-in-dentulous-patients-with-oropharyngeal-cancer-undergoing-radiotherapy-a-retrospective-cohort-study
#20
JOURNAL ARTICLE
Denzel Chin, Hetty Mast, Gerda M Verduijn, Michelle Möring, Steven F Petit, Frederik R Rozema, Eppo B Wolvius, Brend P Jonker, Wilma D Heemsbergen
OBJECTIVES: Patients with head and neck cancer are routinely screened for dental foci prior to radiotherapy (RT) to prevent post- RT tooth extractions associated with an increased risk of osteoradionecrosis. We evaluated the risk factors for post-RT tooth extraction to personalise dental screening and prevention protocols prior to RT. MATERIALS AND METHODS: This retrospective cohort study included dentulous patients diagnosed with oropharyngeal cancer who had undergone radiation therapy at doses 60-70 Gy and achieved a disease-free survival of ≥ 1 year (N = 174)...
May 2024: Clinical and Translational Radiation Oncology
journal
journal
56462
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.